Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Jul. 31, 2020
Sep. 11, 2020
Cover [Abstract]    
Entity Registrant Name PharmaCyte Biotech, Inc.  
Entity Central Index Key 0001157075  
Document Type 10-Q  
Document Period End Date Jul. 31, 2020  
Amendment Flag false  
Current Fiscal Year End Date --04-30  
Entity Filer Category Non-accelerated Filer  
Entity Common Stock, Shares Outstanding   2,333,810,405
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2021  
Entity Current Reporting Status Yes  
Entity Emerging Growth false  
Entity Small Business true  
Entity Shell Company false  
Interactive Data Current? Yes  
Incorporation State NV  
Entity File Number 333-68008